Skip to main content

7 March 2019

7:00 p.m. –  8:00 p.m. CET
6:00 p.m. – 7:00 p.m. GMT

United States
1:00 p.m. – 2:00 p.m. EST
12:00 p.m. – 1:00 p.m. CST
11:00 a.m. – 12:00 p.m. MST
10:00 a.m. – 11:00 a.m. PST


  • Anna T. Pinedo
    T +1 212 506 2275
  • David S. Bakst
    T +1 212 506 2551

Additional Speakers

Polia Nair, Ernst & Young

Preparing Periodic Disclosures for Life Sciences Companies; Areas of SEC Comment

During this webcast, we will review the overall areas of focus identified by the SEC Staff for public companies, the disclosure issues that members of the SEC Staff have highlighted as important for upcoming annual reports on Form 10-K and Form 20-F, and discuss the particular hot button issues for life sciences companies.

Partners Anna Pinedo, David Bakst and Polia Nair (Ernst & Young) will discuss:

  • SEC comment letter trends;
  • Brexit, LIBOR and cyber disclosures;
  • Recent accounting pronouncements;
  • Milestones and collaboration and license agreement related disclosures;
  • Revenue recognition and contingent consideration;
  • Other MD&A disclosures.

CLE credit is pending.

For additional information or to register, please contact Carlos Juarez at or +1 212 506 2770.

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.